Genomma Financial Statements From 2010 to 2024
| LABB Stock | MXN 26.29 0.27 1.04% |
Check Genomma Lab financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genomma Lab's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genomma financial statements analysis is a perfect complement when working with Genomma Lab Valuation or Volatility modules.
Genomma |
Genomma Lab Internacional Company Return On Asset Analysis
Genomma Lab's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Genomma Lab Return On Asset | 0.0921 |
Most of Genomma Lab's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genomma Lab Internacional is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Genomma Lab Internacional has a Return On Asset of 0.0921. This is 101.05% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all Mexico stocks is 165.79% lower than that of the firm.
Genomma Lab Internacional Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genomma Lab's current stock value. Our valuation model uses many indicators to compare Genomma Lab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genomma Lab competition to find correlations between indicators driving Genomma Lab's intrinsic value. More Info.Genomma Lab Internacional is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genomma Lab Internacional is roughly 1.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genomma Lab by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genomma Lab's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Genomma Lab Financial Statements
Genomma Lab investors use historical fundamental indicators, such as Genomma Lab's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genomma Lab. Please read more on our technical analysis and fundamental analysis pages.
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genomma Stock Analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.